US Patent 7741354 Inhibitors of glutaminyl cyclase
Patent 7741354 was granted and assigned to Probiodrug on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+124 characters)
Article
Patent abstract
The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy,
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Andreas Treml0
Michael Altmstetter0
Michael Thormann0
Mirko Buchholz0
Ulrich Heiser0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07741354 Inhibitors of glutaminyl cyclase US Patent 7741354 Inhibitors of glutaminyl cyclase
Infobox
Patent Number
077413540
Patent Number
77413540
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077413540
Date of Patent
June 22, 2010
0Patent Application Number
119371590
Date Filed
November 8, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07741354 Inhibitors of glutaminyl cyclase
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07741354
Date of patent
June 22, 2010
Patent application number
11937159
Date Filed
November 8, 2007
Patent primary examiner
Find more entities like US Patent 7741354 Inhibitors of glutaminyl cyclase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
